Form 4 Tracker
Srinivas Akkaraju

Director; Director, 10% Owner · 7 filings · Latest: Jun 30, 2026

ALUMIS INC.
Kalaris Therapeutics, Inc.
Mineralys Therapeutics, Inc.
Scholar Rock Holding Corp
vTv Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KLRS
Srinivas AkkarajuDirector, 10% OwnerMay 20, 2026
Purchase
$4.83244,300$1.2M2,224,147
KLRS
Srinivas AkkarajuDirector, 10% OwnerDec 18, 2025
Purchase
$10.42479,847$5.0M1,979,847
AKKARAJU SRINIVASDec 30, 2024
Proposed Sale
$0.24719,333$2.3K
SRRK
AKKARAJU SRINIVASOct 7, 2024
Proposed Sale
$29.251,175,713$34.4M